| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.3 | 0.2 |